Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study on Stopping Tocilizumab for Patients with Giant Cell Arteritis
FranceStudy on Long-term Safety of Linerixibat for Treating Itchy Skin in Patients with Primary Biliary Cholangitis
BelgiumStudy on Baricitinib for Treating Children Aged 6 to 17 with Alopecia Areata
FranceStudy on Long-term Safety of Apremilast in Children Aged 6-17 with Moderate to Severe Plaque Psoriasis
BelgiumStudy on the Effects and Safety of Upadacitinib for Children with Polyarticular Juvenile Idiopathic Arthritis
GermanyStudy on Long-term Safety and Efficacy of Pegcetacoplan for Patients with C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
AustriaStudy on the Effects and Safety of Belimumab for Adults with Early Systemic Lupus Erythematosus
FranceStudy Comparing Two Drug Regimens for HIV: Lamivudine and Dolutegravir Sodium vs. Emtricitabine, Tenofovir Alafenamide, and Bictegravir in HIV-Positive Patients
BelgiumStudy on Local Injection of Mesenchymal Stem Cells for Patients with Refractory Crohn's Disease Lesions
BelgiumA Study of Inhaled Sevoflurane Compared to Standard Intravenous Sedation (Dexmedetomidine, Midazolam, or Propofol) in ICU Patients at Risk of Acute Respiratory Distress Syndrome
FranceStudy of intravenous immunoglobulin combined with prednisone compared to prednisone alone in newly diagnosed patients with inflammatory myositis
The NetherlandsStudy on VE202 for Patients with Mild-to-Moderate Ulcerative Colitis
BulgariaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
